Wuhan Easy Diagnosis Biomedicine Co.,Ltd.’s Net Profit Dropped 94.3% in First Quarter of 2023

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (武汉明德生物科技股份有限公司) (002932.SZ) reported a net profit of 81.5 million yuan in the first quarter of 2023, down 94.3% year-on-year.

Meanwhile, the company posted 372.4 million yuan in revenue, down 85% year-on-year.

At the end of the reporting period, it had 8.9 billion yuan in total assets and 2 billion yuan in total liabilities, with a liability-to-asset ratio of 22.6%.